Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nautilus Biotechnology Inc (NQ: NAUT ) 2.600 +0.020 (+0.78%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Nautilus Biotechnology Inc Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 14, 2024 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Reports Second Quarter 2024 Financial Results July 30, 2024 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 July 09, 2024 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference May 23, 2024 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Reports First Quarter 2024 Financial Results April 30, 2024 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 April 11, 2024 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results February 28, 2024 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference February 22, 2024 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 February 07, 2024 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award November 30, 2023 Society award recognizes Dr. Mallick’s decades of innovative leadership and science advancing the field of computational proteomics From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development November 01, 2023 Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteome From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Reports Third Quarter 2023 Financial Results October 31, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023 October 11, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Participate in Upcoming September Investor Conferences September 06, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Participate in Upcoming August Investor Conferences August 04, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Reports Second Quarter 2023 Financial Results August 02, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023 July 11, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Participate in Upcoming June Investor Conferences May 24, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Reports First Quarter 2023 Financial Results May 02, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023 April 18, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference March 23, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Announces “First Access Challenge” Winners March 07, 2023 Researchers from Buck Institute for Research on Aging, Brigham Young University and University of Southern California awarded early access to Nautilus’ single-molecule protein analysis platform From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results February 23, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference February 21, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 January 26, 2023 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Expands to San Diego January 26, 2023 Proteomics company opens new office in Southern California to facilitate ongoing research and team growth aimed at unlocking the potential of the proteome From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG) January 19, 2023 Collaboration enables TGen to gain access to data generated on prototype versions of Nautilus’ next-generation proteome analysis platform to advance the study of a rare childhood cancer From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Launches “First Access Challenge” November 16, 2022 Open competition allows researchers to be among the first to access potentially groundbreaking proteomic data through the testing of twelve samples on Nautilus’ single-molecule protein analysis... From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology Reports Third Quarter 2022 Financial Results November 01, 2022 From Nautilus Biotechnology Inc. Via GlobeNewswire Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 October 05, 2022 From Nautilus Biotechnology Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.